Edwards Lifesciences
1,047 hedge funds and large institutions have $35.1B invested in Edwards Lifesciences in 2020 Q2 according to their latest regulatory filings, with 127 funds opening new positions, 369 increasing their positions, 373 reducing their positions, and 92 closing their positions.
38% more first-time investments, than exits
New positions opened: 127 | Existing positions closed: 92
11% more call options, than puts
Call options by funds: $170M | Put options by funds: $153M
9% more capital invested
Capital invested by funds: $32.1B → $35.1B (+$2.93B)
3% more funds holding
Funds holding: 1,019 → 1,047 (+28)
1% less repeat investments, than reductions
Existing positions increased: 369 | Existing positions reduced: 373
33% less funds holding in top 10
Funds holding in top 10: 21 → 14 (-7)
164.83% less ownership
Funds ownership: 246.68% → 81.85% (-165%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$246M |
| 2 |
A
AustralianSuper
Melbourne,
Australia
|
+$125M |
| 3 |
Swedbank
Stockholm,
Sweden
|
+$111M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$102M |
| 5 |
KBC Group
Brussels,
Belgium
|
+$71.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$458M |
| 2 |
AC
AKO Capital
London,
United Kingdom
|
-$142M |
| 3 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$120M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$108M |
| 5 |
CG
Carmignac Gestion
Paris,
France
|
-$104M |
EW Hedge Fund Activity: Q2 2020 in Review
1,047 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Edwards Lifesciences (EW) for Q2 2020, worth a combined $35.1B — up 9.1% from $32.1B a quarter earlier.
Buyers outnumbered sellers: 127 funds opened new EW positions and 92 closed out — a net gain of 35 holders — while 369 added to existing stakes and 373 trimmed.
The largest buyer was BlackRock, adding an estimated $246M. The largest seller was Fidelity Investments, cutting an estimated $458M.
- 1,047 institutional investors held Edwards Lifesciences (EW) as of Q2 2020, up from 1,019 in Q1 2020.
- Funds reported $35.1B of Edwards Lifesciences stock for Q2 2020, up 9.1% quarter-over-quarter.
- 127 funds opened new Edwards Lifesciences positions in Q2 2020 and 92 closed out, a net change of +35 holders.
- The largest Edwards Lifesciences buyer in Q2 2020 was BlackRock, an estimated $246M added.
- The largest Edwards Lifesciences seller in Q2 2020 was Fidelity Investments, an estimated $458M sold.
Based on aggregated 13F filings for Q2 2020.